Intravascular thrombosis and thromboembolism during liver transplantation: Antifibrinolytic therapy implicated?
暂无分享,去创建一个
[1] R. Porte,et al. Aprotinin and thromboembolism in liver transplantation: is there really a causal effect? , 2002, Anesthesia and analgesia.
[2] C. Legnani,et al. Aprotinin in orthotopic liver transplantation: Evidence for a prohemostatic, but not a prothrombotic, effect , 2001, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[3] S. Aggarwal,et al. Intracardiac thrombus formation and pulmonary thromboembolism immediately after graft reperfusion in 7 patients undergoing liver transplantation , 2001, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[4] D. Raines,et al. Aprotinin administration and pulmonary thromboembolism during orthotopic liver transplantation: report of two cases. , 2001, Anesthesia and analgesia.
[5] E. Norfleet,et al. Fatal thrombosis associated with a hemi-fontan procedure, heparin-protamine reversal, and aprotinin. , 2001, Anesthesiology.
[6] L. Lindgren,et al. Aprotinin and transfusion requirements in orthotopic liver transplantation: a multicentre randomised double-blind study , 2000, The Lancet.
[7] J. Levy,et al. Case 3--1999. Intraoperative coronary thrombosis in association with low-dose aprotinin therapy. , 1999, Journal of cardiothoracic and vascular anesthesia.
[8] M. DePerio,et al. Thromboelastography-guided transfusion algorithm reduces transfusions in complex cardiac surgery. , 1999, Anesthesia and analgesia.
[9] R. Bertina,et al. Activation of the protein C system during cardiopulmonary bypass with and without aprotinin. , 1998, The Annals of thoracic surgery.
[10] B. Chaitman,et al. Analyses of coronary graft patency after aprotinin use: results from the International Multicenter Aprotinin Graft Patency Experience (IMAGE) trial. , 1998, The Journal of thoracic and cardiovascular surgery.
[11] J. Corral,et al. Polymorphisms of platelet membrane glycoprotein Ib associated with arterial thrombotic disease. , 1998, Blood.
[12] T. Zama,et al. Coronary artery disease and polymorphisms in a receptor mediating shear stress-dependent platelet activation. , 1997, Circulation.
[13] M. Ramsay. The use of antifibrinolytic agents results in a reduction in transfused blood products during liver transplantation. , 1997, Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[14] P. Robbins,et al. Use of aprotinin therapy in a patient with factor V Leiden. , 1997, Anesthesia and analgesia.
[15] L. Muhlbaier,et al. Aprotinin: safe and effective only with the full-dose regimen. , 1996, The Annals of thoracic surgery.
[16] M. Ramsay,et al. Brief communications Aprotinin and aortic cannula thrombosis , 1996 .
[17] P. Kuo,et al. Intracardiac thrombus formation during orthotopic liver transplantation: a new entity or an old enemy? , 1996, Transplantation.
[18] M. Ramsay,et al. Aprotinin and aortic cannula thrombosis. , 1996, The Journal of thoracic and cardiovascular surgery.
[19] J. Mark,et al. Early thrombus formation on heparin-bonded pulmonary artery catheters in patients receiving epsilon aminocaproic acid. , 1995, Anesthesiology.
[20] P. Duvaldestin,et al. A fatal thrombotic complication during liver transplantation after aprotinin administration. , 1994, Transplantation.
[21] D. Royston. Intraoperative coronary thrombosis: can aprotinin be incriminated? , 1994, Journal of cardiothoracic and vascular anesthesia.
[22] H. Teufelsbauer,et al. Aprotinin does not decrease early graft patency after coronary artery bypass grafting despite reducing postoperative bleeding and use of donated blood. , 1994, The Journal of thoracic and cardiovascular surgery.
[23] S. Mallett,et al. Aprotinin and reduction of blood loss and transfusion requirements in orthotopic liver transplantation , 1990, The Lancet.
[24] C. Vahl,et al. Early formation of thrombi on pulmonary artery catheters in cardiac surgical patients receiving high-dose aprotinin. , 1990, Journal of cardiothoracic anesthesia.
[25] S. Feinstein,et al. Right Heart Dysfunction, Pulmonary Embolism, and Paradoxical Embolization during Liver Transplantation: A Transesophageal Two‐Dimensional Echocardiographic Study , 1989, Anesthesia and analgesia.
[26] T. Starzl,et al. Systemic effects of tissue plasminogen activator-associated fibrinolysis and its relation to thrombin generation in orthotopic liver transplantation. , 1989, Transplantation.
[27] T. Starzl,et al. Epsilon‐aminocaproic Acid for Treatment of Fibrinolysis during Liver Transplantation , 1987, Anesthesiology.
[28] R. Tubbs,et al. Recurrent subarachnoid hemorrhage associated with aminocaproic acid therapy and acute renal artery thrombosis. Case report. , 1979, Journal of neurosurgery.
[29] A. H. Koo,et al. Cerebral thrombosis associated with Amicar therapy. , 1979, Radiology.